|
Biotecnologia Aplicada
Elfos Scientiae
ISSN: 0684-4551
Vol. 12, Num. 2, 1995, pp. 83
|
Revista Biotecnologia Aplicada 12(2): 83
(1995)
REPORTE CORTO/SHORT REPORT
Presented in the Congress Biotecnologia Habana 94. La Habana,
Cuba, Nov. 28 - Dec. 3, 1994
A SIMPLE VISUAL IMMUNOASSAY (VIA) FOR THE SEMIQUANTITATIVE
DETERMINATION OF Lp(a) BLOOD LEVELS
Gertrudis Rojas^1 and Luis Sorell^2
1^Center for Genetic Engineering and Biotechnology (CIGB), P.O.
Box 6162, Havana 6, C.P.10600. 2^Institute of Angiology and
Vascular Surgery, Calzada del Cerro 1551, Havana, Cuba.
Code Number: BA95024
File Sizes:
Text: 4K
No associated graphics
INTRODUCTION
Lipoprotein (a) (Lp(a)) has been identified as an independent
risk factor for coronary artery disease, stroke and peripheral
atherosclerosis (1).
Individuals with serum Lp(a) levels above 300 mg/L are considered
to have a two-fold increased risk for suffering myocardial
infarction (2). Lp(a) is a low-density lipoprotein-like particle
characterized by the presence of apolipoprotein (a) [apo(a)]
linked to apolipoprotein B. Apo(a) is strikingly homologous to
plasminogen. There are several isoforms of apo(a) which have
different molecular sizes (3). Different commercial immunoassay
kits for measuring Lp(a) are available, like enzyme
immunosorbent-linked assays (ELISA), immunoradiometric assays
(IRMA), and electroimmunoassays (EID) (4). All of them are time-
consuming and require specialized equipment. We describe here the
development of a visual reading immunoassay (VIA) as an
alternative for the semi-quantitative determination of Lp(a)
levels in blood.
EXPERIMENTAL PROCEDURES
Slide-like, opaque-white polystyrene supports whit 12 low-depth
wells each, of the type used by the AuBIODOTTM (CIBG, Havana)
technology, were sensitized by coating with a monoclonal antibody
(Mab) to apo(a). Samples of serum, plasma or whole blood,
appropriately diluted, were incubated in the wells, and the
captured Lp(a) particles recognized by a second Mab to apo(a),
conjugate to colloidal gold. The reaction was finally amplified
with physical developers based on silver ions, rendering an
insoluble product of metalic darkish-black color, proportional
to the amount of Lp(a) in the samples. Three standard samples of
human serum wiht Lp(a) concentrations of 100, 300 and 900 mg/L
were simultaneously analyzed. The intensity of the color
developed for each samples was compared with those of the
standard by a simple visual inspection. The samples were
classified in two categories: those with Lp(a) levels below 300
mg/L and those with Lp(a) levels equal or higher than 300
mg/L.
RESULTS AND DISCUSSION
The Lp(a) levels obtained in the samples were not affected by
plasminogen or apoB concentrations up to 2 mg/mL (5 and 3 times
higher than normal plasminogen or apoB serum levels,
respectively). The method was precise: the results were the same
for each sample analyzed 9 times in the same assay, and 10 times
in the independent assays. Of 92 serum samples studied by the VIA
and a Mab-ELISA developed in our laboratory, 88 were correctly
classified according to Lp(a) levels by our visual system. Three
groups of samples with different apo(a) isoforms were analyzed
by our method, by EID (10 samples), an IRMA kit from Kabi
Pharmacia (7 samples), and an ELISA from Organon technika (15
samples). All of them were correctly classified by our method.
The immunoassay described here is useful for the semi-
quantitative determination of Lp(a) levels, can be done in only
40 minutes without any specialized equipment, and the slides can
be stored indefinitely as a permanent record of results.
REFERENCES
1. BERG, K. (1992). Monograph. hum. Genet. 14:189-207.
2. FULCHER, G. (1992). Aust. NZ J . Med. 22:326-328.
3. MILES, L. et al. (1990). Thromb. Haemostas. 63:331-335.
4. ALBERS, J. (1990). Clin. Chem. 36:2019-2026.
Copyright 1995 Sociedad Iberolatinoamericana de Biotecnologia
Aplicada a la Salud
|